lisdexamfetamine-dimesylate and Glaucoma--Open-Angle

lisdexamfetamine-dimesylate has been researched along with Glaucoma--Open-Angle* in 1 studies

Other Studies

1 other study(ies) available for lisdexamfetamine-dimesylate and Glaucoma--Open-Angle

Article	Year
Bilateral Acute Angle Closure in a Pediatric Patient Taking Lisdexamfetamine Dimesylate (Vyvanse). Journal of glaucoma, 2021, 05-01, Volume: 30, Issue:5 Attention-deficit/hyperactivity disorder is commonly treated with amphetamines as first line therapy. Rare case reports have shown amphetamines are associated with open angle glaucoma. We report a rare case of a 14-year-old male who presented with bilateral acute angle closure presumed to be related to his use of lisdexamfetamine dimesylate (Vyvanse). The patient's medication was discontinued which resulted in complete resolution of angle closure. Topics: Adolescent; Central Nervous System Stimulants; Child; Dextroamphetamine; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lisdexamfetamine Dimesylate; Male; Treatment Outcome	2021

Article

Year

Bilateral Acute Angle Closure in a Pediatric Patient Taking Lisdexamfetamine Dimesylate (Vyvanse).

Journal of glaucoma, 2021, 05-01, Volume: 30, Issue:5

Attention-deficit/hyperactivity disorder is commonly treated with amphetamines as first line therapy. Rare case reports have shown amphetamines are associated with open angle glaucoma. We report a rare case of a 14-year-old male who presented with bilateral acute angle closure presumed to be related to his use of lisdexamfetamine dimesylate (Vyvanse). The patient's medication was discontinued which resulted in complete resolution of angle closure.

Topics: Adolescent; Central Nervous System Stimulants; Child; Dextroamphetamine; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lisdexamfetamine Dimesylate; Male; Treatment Outcome

2021